Asthma Flashcards
Asthma Classifications
Intermittent (persistent cough may be only sign)
Persistent (Mild, Moderate, or Severe)
Intermitten Asthma
Symptoms 2 or fewer days per week Nighttime awakenings 2 or fewer per month SABA needed 2 or fewer days per week No Effect on Normal Activity Normal FEV1 > 80%, and FEV1/FVC normal Step 1
Mild Persistent Asthma
Symptoms 2 or more days per week, but not daily
Nighttime awakenings 3-4 per month
SABA needed 2 or more days per week, but not daily or ever more than once per day
Minor Effect on Normal Activity
FEV1 > 80%, and FEV1/FVC normal
Step 2
Moderate Persistent Asthma
Symptoms daily
Nighttime awakenings more than once a week, but not every night
SABA needed daily
Some Limits on Normal Activity
Normal FEV1 > 60% but < 80%, and FEV1/FVC reduced by 5%
Step 3
Severe Asthma
Symptoms daily, multiple times
Nighttime awakenings often 7 times per week
SABA needed many times per day
Severe Effect on Normal Activity
Normal FEV1 < 60% and FEV1/FVC reduced by more than 5%
Step 4 or 5
Asthma Diagnosis
1 - episodic symptoms of airflow obstruction (wheeze, cough, SOB, decreased PEF)
2 - Evidence that obstruction is partly reversible
3 - Exclusion of other differentials
An FEV1 of 80% of predicted or less with a reduced FEV1/FVC ratio that normalizes or significantly improves with bronchodilator therapy raises the suspicion of asthma.
Asthma Differentials
Stridor from foreign body Tracheomalacia Airway masses vocal cord dysfunction (consider this in athletes before asthma) COPD (not reversible) α1-Antitrypsin (AAT) deficiency
Asthma Risk / Grading
Done at diagnosis and every 1-2 years
Measure personal best FEV1 at start of treatment, then after 3-6 months for new best.
Asthma Step Approach
All steps have a SABA for PRN quick relief
Step 1 - no daily meds
Step 2 - low dose IGC (alt - either LTRA, cromolyn, or theophylline)
Step 3 - Low dose IGC + LABA or Medium dose IGC (alt - low dose IGC + either LTRA, zileuton, or theophylline)
Step 4 - Medium dose IGC + LABA (alt - medium dose IGC + either LTRA, zileuton, or theophylline)
Step 5 - High dose IGC + LABA
Step 6 - High dose IGC + LABA + oral glucocorticoid
Seasonal Asthma
For purely seasonal allergic asthma, start ICS immediately upon onset of symptoms and discontinue using 4 weeks after exposure ends.
Asthma Referral
Emergency evaluation/treatment is indicated for persons with signs and symptoms suggestive of respiratory compromise, including respiratory rate >30/min, pulse rate >120 beats per minute, O2 saturation (on room air) <90%, peak expiratory flow (PEF) <50% predicted or best, drowsiness, confusion, or silent chest.
Aspirin exacerbated respiratory disease
moderate to severe airway obstruction Rhinorrhea sneezing, tearing dermal changes GI disturbances
All on exposure to aspirin or other prostaglandin inhibitors
Asthma and GERD
Another exacerbating factor of asthma is esophageal reflux of gastric contents. The incidence of gastroesophageal reflux in adults with asthma ranges from 25% to 80%. Gastroesophageal reflux resulting in distal esophageal stimulation with acid may cause bronchoconstriction or may increase bronchial reactivity through vagal mechanisms.
Classic Asthma Presentation
Episodic wheezing associated with dyspnea, cough, sputum production
PEF Zones
Green >80%
Yellow 60% to 80%
Red <60%
Some scales use 60%, some use 50%. Yellow = step up, Green = step down, Red = urgent intervention and step up